178 related articles for article (PubMed ID: 22945915)
1. 3,4-dimethoxyphenyl bis-benzimidazole, a novel DNA topoisomerase inhibitor that preferentially targets Escherichia coli topoisomerase I.
Bansal S; Sinha D; Singh M; Cheng B; Tse-Dinh YC; Tandon V
J Antimicrob Chemother; 2012 Dec; 67(12):2882-91. PubMed ID: 22945915
[TBL] [Abstract][Full Text] [Related]
2. Benzimidazoles: Selective Inhibitors of Topoisomerase I with Differential Modes of Action.
Bansal S; Sur S; Tandon V
Biochemistry; 2019 Feb; 58(6):809-817. PubMed ID: 30628776
[TBL] [Abstract][Full Text] [Related]
3. Old class but new dimethoxy analogue of benzimidazole: a bacterial topoisomerase I inhibitor.
Bansal S; Tawar U; Singh M; Nikravesh A; Good L; Tandon V
Int J Antimicrob Agents; 2010 Feb; 35(2):186-90. PubMed ID: 20006473
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel bisbenzimidazoles as Escherichia coli topoisomerase IA inhibitors and potential antibacterial agents.
Nimesh H; Sur S; Sinha D; Yadav P; Anand P; Bajaj P; Virdi JS; Tandon V
J Med Chem; 2014 Jun; 57(12):5238-57. PubMed ID: 24856410
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, evaluation, and CoMFA study of fluoroquinophenoxazine derivatives as bacterial topoisomerase IA inhibitors.
Yu X; Zhang M; Annamalai T; Bansod P; Narula G; Tse-Dinh YC; Sun D
Eur J Med Chem; 2017 Jan; 125():515-527. PubMed ID: 27689733
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics.
Alt S; Mitchenall LA; Maxwell A; Heide L
J Antimicrob Chemother; 2011 Sep; 66(9):2061-9. PubMed ID: 21693461
[TBL] [Abstract][Full Text] [Related]
7. Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition.
Hoshino K; Kitamura A; Morrissey I; Sato K; Kato J; Ikeda H
Antimicrob Agents Chemother; 1994 Nov; 38(11):2623-7. PubMed ID: 7872758
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of novel inhibitors of topoisomerase I: 2-aryl-substituted 2-bis-1H-benzimidazoles.
Singh M; Tandon V
Eur J Med Chem; 2011 Feb; 46(2):659-69. PubMed ID: 21186067
[TBL] [Abstract][Full Text] [Related]
9. Small-Molecule Inhibitors Targeting Topoisomerase I as Novel Antituberculosis Agents.
Sandhaus S; Annamalai T; Welmaker G; Houghten RA; Paz C; Garcia PK; Andres A; Narula G; Rodrigues Felix C; Geden S; Netherton M; Gupta R; Rohde KH; Giulianotti MA; Tse-Dinh YC
Antimicrob Agents Chemother; 2016 Jul; 60(7):4028-36. PubMed ID: 27114277
[TBL] [Abstract][Full Text] [Related]
10. Selective Inhibition of Escherichia coli RNA and DNA Topoisomerase I by Hoechst 33258 Derived Mono- and Bisbenzimidazoles.
Ranjan N; Story S; Fulcrand G; Leng F; Ahmad M; King A; Sur S; Wang W; Tse-Dinh YC; Arya DP
J Med Chem; 2017 Jun; 60(12):4904-4922. PubMed ID: 28513176
[TBL] [Abstract][Full Text] [Related]
11. A Fluorescence-Based Assay for Identification of Bacterial Topoisomerase I Poisons.
Annamalai T; Cheng B; Keswani N; Tse-Dinh YC
Methods Mol Biol; 2018; 1703():259-268. PubMed ID: 29177747
[TBL] [Abstract][Full Text] [Related]
12. Symmetric bis-benzimidazoles are potent anti-staphylococcal agents with dual inhibitory mechanisms against DNA gyrase.
Dale AG; Hinds J; Mann J; Taylor PW; Neidle S
Biochemistry; 2012 Jul; 51(29):5860-71. PubMed ID: 22746203
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914.
Kern G; Palmer T; Ehmann DE; Shapiro AB; Andrews B; Basarab GS; Doig P; Fan J; Gao N; Mills SD; Mueller J; Sriram S; Thresher J; Walkup GK
J Biol Chem; 2015 Aug; 290(34):20984-20994. PubMed ID: 26149691
[TBL] [Abstract][Full Text] [Related]
14. 1H-Benzimidazole derivatives as mammalian DNA topoisomerase I inhibitors.
Alpan AS; Gunes HS; Topcu Z
Acta Biochim Pol; 2007; 54(3):561-5. PubMed ID: 17823665
[TBL] [Abstract][Full Text] [Related]
15. DNA topoisomerases as targets for the anticancer drug TAS-103: DNA interactions and topoisomerase catalytic inhibition.
Fortune JM; Velea L; Graves DE; Utsugi T; Yamada Y; Osheroff N
Biochemistry; 1999 Nov; 38(47):15580-6. PubMed ID: 10569942
[TBL] [Abstract][Full Text] [Related]
16. Covalent Complex of DNA and Bacterial Topoisomerase: Implications in Antibacterial Drug Development.
Tiwari PB; Chapagain PP; Seddek A; Annamalai T; Üren A; Tse-Dinh YC
ChemMedChem; 2020 Apr; 15(7):623-631. PubMed ID: 32043806
[TBL] [Abstract][Full Text] [Related]
17. Analysis of RuvABC and RecG involvement in the escherichia coli response to the covalent topoisomerase-DNA complex.
Sutherland JH; Tse-Dinh YC
J Bacteriol; 2010 Sep; 192(17):4445-51. PubMed ID: 20601468
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Zn(II) binding type IA topoisomerases by organomercury compounds and Hg(II).
Cheng B; Annamalai T; Sandhaus S; Bansod P; Tse-Dinh YC
PLoS One; 2015; 10(3):e0120022. PubMed ID: 25798600
[TBL] [Abstract][Full Text] [Related]
19. Isolation and quantitation of topoisomerase complexes accumulated on Escherichia coli chromosomal DNA.
Aedo S; Tse-Dinh YC
Antimicrob Agents Chemother; 2012 Nov; 56(11):5458-64. PubMed ID: 22869559
[TBL] [Abstract][Full Text] [Related]
20. Topoisomerase I function during Escherichia coli response to antibiotics and stress enhances cell killing from stabilization of its cleavage complex.
Liu IF; Sutherland JH; Cheng B; Tse-Dinh YC
J Antimicrob Chemother; 2011 Jul; 66(7):1518-24. PubMed ID: 21486853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
